跳至主要内容
临床试验/JPRN-UMIN000025010
JPRN-UMIN000025010已完成2 期

Induction Chemotherapy and Adjuvant Thoracic Radiation in Resectable Stage N2-3A/3B Non-small Cell Lung Cancer (ICAT study) - Trimodality with Adjuvant Radiation in Stage N2-3A/3B Non-small Cell Lung Cancer

Kyoto Prefectural University of Medicine0 个研究点目标入组 1 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
1

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Evident unresectable extranodal lymph node involvement in CT scanning 2.Contraindication to either carboplatin or nab-paclitaxel 3.History of severe drug hypersensitivity 4.Impaired pulmonary function 5.Myocardial infarction within 6 months (180 days) prior to consent 6.Interstitial pneumonia, pulmonary fibrosis suspected or diagnosed within 56 days prior to consent 7.Administration of prednisolone > 10mg/day within 90 days prior to consent 8.Clinically severe heart diseases 9.Clinically severe psychiatric diseases 10.Uncontrollable diabetes mellitus 11.Clinically active infection 12.Any other severe complication 13.Active double malignancies 14.Pregnant, lactating or possibly pregnant 15.Any other unsuitable reasons judged by attending investigators

研究者

相似试验